MedPath

nani formulation in Pelvic Inflammatory Disease

Phase 2
Conditions
Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhereHealth Condition 2: N74- Female pelvic inflammatory disorders in diseases classified elsewhere
Registration Number
CTRI/2019/03/018232
Lead Sponsor
ational institute of Unani medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Married women age group of 20-40 years

Mild to moderate PID as per CDC Criteria (CDC diagnostic criteria i.e. pelvic

or lower abdominal pain and uterine / adnexal or cervical motion tenderness and

more than or equal to 1 of its minor criteria i.e. fever(101 degree F), abnormal cervical or vaginal

mucopurulent discharge, abundant number of WBC on wet mount test of vaginal fluid, elevated ESR or CRP, positive test for cervical infection with N.

gonorrhoea or C. trachomatis include in this criteria)

Medical diagnosis of uncomplicated pelvic inflammatory disease(Sub-acute

PID with mild to moderate signs and symtoms)

Exclusion Criteria

Severe PID and its Complications

Pregnant and lactating women

Systemic illnesses and malignancies

A history of uterine or pelvic or abdominal surgery and less than 30days before treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
change in subjective parameters.Timepoint: before and after treatment
Secondary Outcome Measures
NameTimeMethod
change in objective parametersTimepoint: before and after treatment
© Copyright 2025. All Rights Reserved by MedPath